1. Home
  2. RNXT vs ASRV Comparison

RNXT vs ASRV Comparison

Compare RNXT & ASRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • ASRV
  • Stock Information
  • Founded
  • RNXT 2012
  • ASRV 1983
  • Country
  • RNXT United States
  • ASRV United States
  • Employees
  • RNXT N/A
  • ASRV N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • ASRV Major Banks
  • Sector
  • RNXT Health Care
  • ASRV Finance
  • Exchange
  • RNXT Nasdaq
  • ASRV Nasdaq
  • Market Cap
  • RNXT 44.0M
  • ASRV 48.4M
  • IPO Year
  • RNXT 2021
  • ASRV N/A
  • Fundamental
  • Price
  • RNXT $1.11
  • ASRV $3.05
  • Analyst Decision
  • RNXT Strong Buy
  • ASRV
  • Analyst Count
  • RNXT 2
  • ASRV 0
  • Target Price
  • RNXT $7.50
  • ASRV N/A
  • AVG Volume (30 Days)
  • RNXT 552.5K
  • ASRV 37.0K
  • Earning Date
  • RNXT 11-13-2025
  • ASRV 10-21-2025
  • Dividend Yield
  • RNXT N/A
  • ASRV 3.93%
  • EPS Growth
  • RNXT N/A
  • ASRV N/A
  • EPS
  • RNXT N/A
  • ASRV 0.30
  • Revenue
  • RNXT $662,000.00
  • ASRV $53,488,000.00
  • Revenue This Year
  • RNXT $2,895.35
  • ASRV N/A
  • Revenue Next Year
  • RNXT $313.04
  • ASRV N/A
  • P/E Ratio
  • RNXT N/A
  • ASRV $10.17
  • Revenue Growth
  • RNXT N/A
  • ASRV 17.45
  • 52 Week Low
  • RNXT $0.75
  • ASRV $2.03
  • 52 Week High
  • RNXT $1.69
  • ASRV $3.42
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 46.69
  • ASRV 49.76
  • Support Level
  • RNXT $0.98
  • ASRV $3.01
  • Resistance Level
  • RNXT $1.15
  • ASRV $3.19
  • Average True Range (ATR)
  • RNXT 0.09
  • ASRV 0.20
  • MACD
  • RNXT -0.01
  • ASRV -0.00
  • Stochastic Oscillator
  • RNXT 39.99
  • ASRV 39.58

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About ASRV AmeriServ Financial Inc.

AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.

Share on Social Networks: